About a decade ago, the concepts of Quality by Design were introduced into pharmaceutical regulatory processes and the industry has increasingly adopted these systemic approaches into their manufacturing operations. Among the paradigm shifts were the relating of the product quality to its manufacturing processes, and the management of the identified risks. CoRE invites you to attend this seminar given by Dr Moheb Nasr. Dr. Moheb Nasr is currently the Vice President, CMC Regulatory Strategy, GSK. Prior to joining GSK, Dr Nasr worked at the US FDA being responsible for the development of the QdD concept. Today Dr Nasr will share his experiences from the the journey from inception to implementation of QbD over the years.